- Investigators
- John S Anderson, Jason A Piraino
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease) -
SWAP 7 - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
A multicenter randomized controlled trial to establish the impact of MeMed BV簧 on management of patients with suspected Lower Respiratory Tract Infections - Investigator
- Phyllis L Hendry
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
Precision Cancer Survivorship Cohort - Ages
- 18 Years - N/A
- Sexes
- All
-
Access BNP Assay Clinical Subject Sample Collection Enrollment Study Protocol - Investigators
- Christine N Gage, Phyllis L Hendry
- Ages
- 22 Years - 100 Years
- Sexes
- All
-
Dal-Gene-2 - Investigator
- Dominick J Angiolillo
- Ages
- 45 Years - 99 Years
- Sexes
- All
-
SWAP 9 - Investigator
- Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All